Detalhe da pesquisa
1.
The role of hepatic macrophages in liver metastasis.
Cell Immunol
; 330: 202-215, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29661474
2.
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment.
Front Immunol
; 13: 1003975, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36531986
3.
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.
Cancer Res
; 82(20): 3785-3801, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979635
4.
Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth.
Front Immunol
; 12: 772555, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34925341
5.
IL1ß Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D.
Cancer Immunol Res
; 9(3): 309-323, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33361087
6.
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy.
J Immunother Cancer
; 9(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589525
7.
Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.
Front Immunol
; 9: 2250, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30349530
8.
Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages.
FEBS J
; 285(4): 777-787, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28834216
9.
Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapies.
J Leukoc Biol
; 102(2): 317-324, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389620